Zhe Zhang

3 weeks ago | dx.doi.org | Zile Wang |Bo Lai |Zhe Zhang |Chenyuan Chang

1 month ago | nature.com | Yiyong Xian |Fang Liu |Zhe Zhang |Lingling Niu |Wanru Shi |Xiaoying Wang | +3 more

To compare the long-term outcomes of monovision surgery using implantable collamer lens (ICL) V4c and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) in myopic patients with early presbyopia. This case series study included 48 eyes of 24 patients (male/female: 10/14, mean age 45.50 ± 3.82 years) and followed-up for 4.5 years (54.00 ± 9.77 months). Patients were examined for spherical equivalent, uncorrected distance visual acuity, corrected distance visual acuity, intraocular pressure, presbyopic add power, visual acuity (VA) (logMAR) of dominant eyes (D-eye), non-dominant eyes (nD-eye), and both eyes (Bi) at 0.4 m, 0.8 m, and 5 m, corneal wavefront aberration, and contrast sensitivity (CS). All surgeries were uneventful. The safety indices of ICL V4c group and FS-LASIK group were 1.17 ± 0.30 and 0.98 ± 0.20 (p < 0.05), and the efficacy indices were 0.79 ± 0.07 and 0.52 ± 0.07 (p < 0.05) respectively. The binocular VA (logMAR) of ICL V4c group and FS-LASIK group at 5.0 m were: 0.02 ± 0.11, 0.18 ± 0.30; 0.8 m: 0.09 ± 0.12, − 0.01 ± 0.11; 0.4 m: − 0.02 ± 0.06, − 0.03 ± 0.08, (p > 0.05 at three distances). Compared with ICL V4c group, lower CS was observed at 1.0 cpd in the FS-LASIK group (1.07 ± 0.31 vs. 0.80 ± 0.51, p = 0.043). Monovision surgery using ICL V4c and FS-LASIK provides good binocular visual acuity at near-to-far distances in myopia patients in the presbyopia age group.

2 months ago | mdpi.com | Jinjie Wang |Jianli Ding |Zhe Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jan 16, 2025 | mdpi.com | Mingxiao Shao |Yizhe Fan |Yan Zhang |Zhe Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Nov 4, 2024 | dx.doi.org | Shahadat Hossain |Alex Wang |Zhe Zhang |Salma Anika

1. IntroductionClick to copy section linkSection link copied!Gene fusion, the recombination of distinct genes to create multifunctional proteins, acts as a creative force in evolutionary biology by allowing organisms to merge functional characteristics of individual proteins and adapt to environmental changes. (1) Advances in genetic engineering have rendered gene fusion a powerful strategy for merging the functional properties of proteins with the versatility of nanomaterials.